Blood Flow Restriction Rehab to Improve Mobility and Balance in COPD Patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial investigates the effects of Blood Flow Restriction (BFR) resistance exercise on functional mobility and balance in adults with COPD. Participants aged 45-60 with stable COPD are assigned to either a standard physical therapy or a BFR-assisted resistance program without tourniquets, conducted at multiple hospitals in Lahore. The study compares outcomes related to mobility and balance to determine if BFR provides additional benefit. Eligibility includes specific lung function criteria and overall clinical stability, while safety exclusions cover major surgeries, cancer, open fractures, cognitive disorders, active malignancy, and severe hypertension. The trial is led by Rashid Latif Medical College with collaboration at Arif Memorial Teaching Hospital.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subjects who are clinically stable before study
* Forced expiratory volume in 1s (FEV1)/forced vital capacity (FVC)\<70% and FEV1 ≥30% but \<80% respectively
* Subjects who will be willing to take part in this study

Exclusion Criteria:

* Upper abdominal surgery
* Lung cancer
* Open fracture
* Mental disorder
* Active malignancy
* Severe hypertension

Where it's running

• Arif Memorial Teaching Hospital
  Lahore, Pakistan Recruiting

Study contacts

• Principal investigator: Harmeen Nadeem — Arif Memorial Teaching Hospital
• Study coordinator: Aleena Waheed, Masters in Physical Therapy
• Email: alwaheed28@gmail.com
• Phone: 03214883868

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Chronic Respiratory Disease Participant Engagement

  This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.

  Recruiting Richmond Pharmacology Limited · London · NCT07924462

• IOS-based platform to screen, diagnose, and manage COPD and asthma

  This study tests an Impulse Oscillometry system to screen for and diagnose COPD and asthma and to help predict flare-ups over about a year, involving adults in China.

  Recruiting Beijing Chao Yang Hospital · Beijing, Beijing Municipality · NCT07910409

• Targeted NMES to improve breathing and leg/extra muscle strength in COPD

  This study tests whether targeted neuromuscular electrical stimulation helps people with COPD see improvements in breathing muscle function and overall muscle strength.

  Recruiting Universitas Padjadjaran · Bandung, West Java · NCT07910006

• AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer

  This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.

  Recruiting Phase 2 AeroRx Therapeutics Inc. · London and 1 other locations · NCT07896252

• PBMT with a pulmonary rehab program for COPD patients

  A small randomized trial tests whether adding photobiomodulation therapy before exercise in a COPD pulmonary rehab program helps improve functional capacity.

  Recruiting Federal University of Health Science of Porto Alegre · Porto Alegre, Rio Grande do Sul · NCT07878884

• Controlled versus standard oxygen therapy for ICU COPD with acute exacerbation

  This trial tests whether keeping oxygen levels at 88-92% helps ICU patients with an acute COPD flare more than keeping levels above 94%.

  Recruiting Hôpital Universitaire Taher Sfar · Mahdia, Mahdia Governorate and 1 other locations · NCT07842510

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.